Association between Smoking and Overall and Specific Mortality in Patients with Bladder Cancer: A Population-based Study [0.03%]
吸烟与膀胱癌患者总体死亡率及特定死亡率的关联：基于人群的研究
Chung-Han Ho,Wen-Hsin Tseng,Steven K Huang et al.
Chung-Han Ho et al.
Background: The role of smoking in the prognosis of bladder cancer may significantly impact clinical management. It is also a considerable burden to Taiwan's economy and health of its citizens. ...
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter [0.03%]
低剂量膀胱内卡介苗（BCG）为什么可能无关紧要？
Ashish M Kamat,Niyati Lobo,Seth P Lerner et al.
Ashish M Kamat et al.
When it comes to the treatment of patients with non-muscle-invasive bladder cancer (NMIBC) with intravesical bacillus Calmette-Guérin (BCG), two questions must be considered: 1) what dose to give, and 2) for how long? The issue of optimal ...
A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation [0.03%]
新型功能基因锌指蛋白485(ZNF485)与膀胱癌增殖有关
Yiao Tan,Fangfang Zhao,Shuhan Liu et al.
Yiao Tan et al.
Background: Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in diagnostics and treatment greatly impedes the survival of bladder canc...
Predictive Value of Computed Tomography Following Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer [0.03%]
新辅助化疗后肌层浸润性膀胱癌的CT评估价值研究
Syed M Alam,Austin Martin,Matthew T McLeay nd et al.
Syed M Alam et al.
Background: Neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) remains standard treatment for select patients with muscle-invasive bladder cancer (MIBC). Although computed tomography (CT) is often obtained pr...
Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy [0.03%]
环孢素单核细胞组蛋白H3三甲基化与BCG诱导治疗后膀胱癌患者早期复发缺乏的相关性
Jean-Françcois Paré,Maryam Tabasinezhad,Arielle Grossman et al.
Jean-Françcois Paré et al.
Background: The mode of action of Bacillus Calmette-Guérin (BCG) in the treatment of patients with non-muscle invasive bladder cancer (NMIBC) is incompletely understood, but recent studies support an association between ...
Challenging Cases in Urothelial Cancer: Case 28: Lynch Syndrome [0.03%]
泌尿系肿瘤疑难病历讨论：病例28：林奇综合征患者术后复发转移的诊治策略
Mark S Soloway
Mark S Soloway
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer [0.03%]
低分割放射治疗（Hypo-RT）治疗局限性膀胱癌
Assaf Moore,Stephanie M Lobaugh,Zhigang Zhang et al.
Assaf Moore et al.
Background: Various radiotherapeutic regimens are used in the treatment of bladder cancer. Objective: We aimed to evaluate early toxici...
Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer [0.03%]
电动力药物灌注化疗与卡介苗膀胱灌注治疗非肌层浸润性膀胱癌的疗效比较研究
María Teresa Melgarejo Segura,Ana Morales Martínez,Yaiza Yáñez Castillo et al.
María Teresa Melgarejo Segura et al.
Background: Devices that increase the penetrance of intravesical chemotherapeutics are emerging as alternatives to classical Bacillus Calmette Guérin (BCG) treatment. ...
Neoadjuvant Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer [0.03%]
非肌层浸润性膀胱癌的术前腔内化疗
Edward M Messing
Edward M Messing